Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.

WK Kellogg Co.’s stock fell 1.8% Tuesday after the breakfast-cereal company’s fourth-quarter adjusted profit swept past ...

Since the start of 2025, Oklo Inc. (OKLO) has been on a remarkable rise, catching the attention of investors, analysts, and ...

One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...

Nathan Eigerman: The Value Line® Index* represents a higher dividend yield core U.S. equity portfolio. Some investors are ...

The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

RBC Capital raised the firm’s price target on Volvo (VLVLY) to SEK 307 from SEK 294 and keeps a Sector Perform rating on the shares.Maximize ...

Here's why this Sam Altman-backed nuclear energy company almost soared more than 150% in 2025 and why it'll likely continue ...

The company, backed by market investor Rekha Jhunjhunwala, recently unveiled its financial performance for the quarter and ...

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.